Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
Ramakers-van Woerden
N L
NL
Pieters
R
R
Rots
M G
MG
van Zantwijk
C H
CH
Noordhuis
P
P
Beverloo
H B
HB
Peters
G J
GJ
van Wering
E R
ER
Camitta
B M
BM
Pui
C-H
CH
Relling
M V
MV
Evans
W E
WE
Veerman
A J P
AJ
D000964:Antimetabolites, Antineoplastic / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology; D001773:Blood Cells / Q000378:metabolism / Q000473:pathology; D001854:Bone Marrow Cells / Q000378:metabolism / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008727:Methotrexate / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D004791:Enzyme Inhibitors; D008727:Methotrexate